Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study

NCT01946919 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT01946919
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01946919 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Marketing Surveillance of the Cinepazide Maleate Injection: a Real World Study
Lead sponsor
Peking University Third Hospital
Phase
Observational
Overall status
Completed
Start date
October 31, 2012
Completion date
June 30, 2022
Enrollment
18,260 (actual)
Sites
61

Conditions

As the registry lists them; a condition with its own page is linked.

adverse drug reaction, cinepazide, stroke